Drug Repositioning: Current Advances and Future Perspectives

Drug repositioning is the process of identifying new indications for existing drugs. At present, the conventional de novo drug discovery process requires an average of about 14 years and US$2.5 billion to approve and launch a drug. Drug repositioning can reduce the time and cost of this process beca...

Full description

Bibliographic Details

Main Authors:	Yuhei Nishimura, Hideaki Hara
Format:	Online
Language:	English
Published:	Frontiers Media SA 2021
Subjects:	RM1-950 Q1-390 database Integrative strategies molecular docking polypharmacology multi-omics computational analysis Drug Repositioning data sharing Patenting thema EDItEUR::M Medicine and Nursing::MK Medical specialties, branches of medicine::MKG Pharmacology
Online Access:	32072
Tags:	Add Tag No Tags, Be the first to tag this record!